Ledger.Open graph →

SEC Form D · filed March 28, 2012

Solace Therapeutics Inc

Offering

$20.0M

Sold

$7.0M

Exemption

—

Industry

Other Health Care

Location

FRAMINGHAM, MA

Type

—

People & firms on this filing (6)

Miguel A. Loya · Houston, TXExec · Director Chris Gandy · Honolulu, HIExec · Director William R. Ford · Washington, Washington, D.C.Exec · Director Anthony M. Nee · Washington, Washington, D.C.Exec · Director Dr. William D. Pintauro · Framingham, MADirector J. D. Cole · Framingham, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗